Immuneering (IMRX) Accumulated Depreciation & Amortization (2020 - 2024)
Immuneering (IMRX) has 4 years of Accumulated Depreciation & Amortization data on record, last reported at $88949.0 in Q3 2024.
- For Q3 2024, Accumulated Depreciation & Amortization fell 61.83% year-over-year to $88949.0; the TTM value through Sep 2024 reached $88949.0, down 61.83%, while the annual FY2023 figure was $322816.0, 22.83% down from the prior year.
- Accumulated Depreciation & Amortization reached $88949.0 in Q3 2024 per IMRX's latest filing, down from $90533.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $418337.0 in Q4 2022 and bottomed at $76527.0 in Q1 2023.
- Average Accumulated Depreciation & Amortization over 4 years is $172453.8, with a median of $151097.0 recorded in 2021.
- Peak YoY movement for Accumulated Depreciation & Amortization: soared 140.12% in 2022, then tumbled 61.83% in 2024.
- A 4-year view of Accumulated Depreciation & Amortization shows it stood at $174219.0 in 2021, then skyrocketed by 140.12% to $418337.0 in 2022, then decreased by 22.83% to $322816.0 in 2023, then crashed by 72.45% to $88949.0 in 2024.
- Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $88949.0 in Q3 2024, $90533.0 in Q2 2024, and $90209.0 in Q1 2024.